KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Total Non-Current Liabilities (2020 - 2025)

AbCellera Biologics' Total Non-Current Liabilities history spans 6 years, with the latest figure at $323.2 million for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities rose 37.41% year-over-year to $323.2 million, compared with a TTM value of $323.2 million through Sep 2025, up 37.41%, and an annual FY2024 reading of $227.9 million, up 5.12% over the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $323.2 million at AbCellera Biologics, down from $328.0 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $328.0 million in Q2 2025, with the low at $83.0 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $207.1 million, with a median of $216.8 million recorded in 2023.
  • Year-over-year, Total Non-Current Liabilities surged 140.66% in 2021 and then grew 3.45% in 2024.
  • Tracing ABCL's Total Non-Current Liabilities over 5 years: stood at $172.2 million in 2021, then increased by 9.96% to $189.3 million in 2022, then grew by 14.5% to $216.8 million in 2023, then rose by 5.12% to $227.9 million in 2024, then soared by 41.82% to $323.2 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Total Non-Current Liabilities are $323.2 million (Q3 2025), $328.0 million (Q2 2025), and $245.8 million (Q1 2025).